Open Access<p>Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden</p>
Author(s) -
Marie Linder,
Anastasia Nyman,
Helle Kieler,
Bengt Danielsson,
Natalia Borg,
Marcus Gry,
Julius Collin
Publication year - 2020
Publication title -
clinical epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.868
H-Index - 58
ISSN - 1179-1349
DOI - 10.2147/clep.s258373
Subject(s) - medicine , dabigatran , apixaban , atrial fibrillation , hazard ratio , warfarin , rivaroxaban , direct thrombin inhibitor , discovery and development of direct thrombin inhibitors , cohort , propensity score matching , population , confidence interval , thrombin , platelet , environmental health
To evaluate associations between first-time use of direct oral anticoagulants or vitamin K antagonists and bleeding risk or mortality in the elderly with atrial fibrillation in a real-world setting in Sweden.